VTGN EPS Estimates
VistaGen Therapeutics, Inc.
$0.21
-$0.01(-3.82%)
38
Overall
60
Value
18
Tech
36
Quality
Market Cap
$9.17M
Volume
945.49K
52W Range
$0.20 - $1.03
Target Price
$0.97
VTGN EPS estimates: the consensus estimate for VistaGen Therapeutics, Inc.'s current fiscal year is -$1.45 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VTGN EPS Estimates
- EPS estimate, current quarter
- $-0.37
- EPS estimate, next quarter
- $-0.36
- EPS estimate, current year
- $-1.45
- EPS estimate, next year
- $-1.54
- EPS growth, 3-year
- +40.09%
| Fiscal year | EPS |
|---|---|
| 2026 | $-1.83 |
| 2025 | $-1.67 |
| 2024 | $-1.52 |
| 2023 | $-8.51 |
| 2022 | $-7.50 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTGN | $0.21 | -3.8% | 945.49K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get VistaGen Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW